SetPoint Medical

About:

SetPoint Medical develops novel therapeutics for the treatment of chronic autoimmune conditions.

Website: http://www.setpointmedical.com

Twitter/X: SetPointMed

Top Investors: Norwest Venture Partners, Runway Growth Capital, Boston Scientific, New Enterprise Associates, Medtronic

Description:

SetPoint Medical is a privately held clinical-stage healthcare company dedicated to treating patients with chronic autoimmune diseases. The company is developing a novel platform designed to stimulate the vagus nerve to activate the inflammatory reflex to produce a systemic immune-restorative effect. SetPoint Medical’s platform technology is designed to offer patients and providers a treatment alternative for rheumatoid arthritis, inflammatory bowel disease and other chronic autoimmune conditions with potentially less risk and cost than drug therapy.

Total Funding Amount:

$344M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Valencia, California, United States

Founded Date:

2007-01-01

Contact Email:

info(AT)setpointmedical.com

Founders:

Jim Broderick, Kevin Tracey, Shaw Warren

Number of Employees:

101-250

Last Funding Date:

2023-01-19

IPO Status:

Private

© 2025 bioDAO.ai